TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Swedish Orphan Biovitrum International AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
23,253
|
23,921
|
23,458 |
Financial expenses |
92,684
|
98,303
|
97,586 |
Earnings before taxes |
-65,126
|
-95,496
|
-149,088 |
EBITDA |
21,929
|
1,311
|
-30,549 |
Total assets |
5,638,753
|
6,007,927
|
5,787,049 |
Current assets |
34,453
|
422,216
|
189,551 |
Current liabilities |
103,237
|
14,899
|
16,237 |
Equity capital |
1,396,268
|
1,234,535
|
1,076,700 |
- share capital |
622
![]() |
622
![]() |
622 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
24.8%
|
20.5%
|
18.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
-280.1%
|
-399.2%
|
-635.6% |
Return on assets (ROA) |
0.5%
|
0.0%
|
-0.9% |
Current ratio |
33.4%
|
2833.9%
|
1167.4% |
Return on equity (ROE) |
-4.7%
|
-7.7%
|
-13.8% |
Change turnover |
-668
|
463
|
-10,503 |
Change turnover % |
-3%
|
2%
|
-31% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.